Fresh Tracks Therapeutics, Inc.

Details:

Details about Fresh Tracks Therapeutics, Inc.

On September 18, 2023, Fresh Tracks Therapeutics’ Board of Directors (the “Board”) unanimously approved the Company’s proposed liquidation and dissolution (the “Dissolution”) and a proposed plan of liquidation and dissolution (the…

[email protected]

Employees:

Employees at Fresh Tracks Therapeutics, Inc.

Nathan Sampson

Senior Business Analyst at Fresh Tracks Therapeutics, Inc.

Steven Petersen

General Counsel at Fresh Tracks Therapeutics, Inc.

Fernando Bacala

Fresh Tracks Therapeutics, Inc.

Steven Kradjian

President and Principal Regulatory Consultant at Fresh Tracks Therapeutics, Inc.

Robin Mere

Associate Director, Portfolio and Project Management at Fresh Tracks Therapeutics, Inc.

Larry Smith

Vice President Nonclinical Development at Fresh Tracks Therapeutics, Inc.

Robin Mere

Fresh Tracks Therapeutics, Inc.

Julie Lees

Principal Quality Specialist at Fresh Tracks Therapeutics, Inc.

Frank Silanos

Vice President, Finance and Accounting at Fresh Tracks Therapeutics, Inc.

Amit Vasavada

Manager, Algal Bioproducts (Biofuels, Aquaculture and Nutrition Bioproducts) at Fresh Tracks Therapeutics, Inc.

Greg Skinner

Partner at Fresh Tracks Therapeutics, Inc.

Alice Chu

Statistical Consultant at Fresh Tracks Therapeutics, Inc.

Peggy Lalor

Fresh Tracks Therapeutics, Inc.

Gregory Grose

Owner at Fresh Tracks Therapeutics, Inc.

Pamela Resch

Sr Exec Director, Regulatory Affairs at Fresh Tracks Therapeutics, Inc.

David Starr

Technical Specialist, Molecular Pharmaceutics at Fresh Tracks Therapeutics, Inc.

Robin Jackman

Founder and CEO at Fresh Tracks Therapeutics, Inc.